Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 21264909)

1.

Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.

Opelz G, Daniel V, Naujokat C, Döhler B.

Transplantation. 2009 Oct 27;88(8):962-7. doi: 10.1097/TP.0b013e3181b9692d.

PMID:
19855238
2.

Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.

van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM.

Blood. 2009 Jul 16;114(3):630-7. doi: 10.1182/blood-2009-02-202507. Epub 2009 May 14.

3.

Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients.

Morton LM, Landgren O, Chatterjee N, Castenson D, Parsons R, Hoover RN, Engels EA.

Blood. 2007 Dec 15;110(13):4599-605. Epub 2007 Sep 12.

4.

The non-Hodgkin lymphomas: a review of the epidemiologic literature.

Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D.

Int J Cancer. 2007;120 Suppl 12:1-39. Review.

PMID:
17405121
5.

Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.

Caillard S, Lelong C, Pessione F, Moulin B; French PTLD Working Group.

Am J Transplant. 2006 Nov;6(11):2735-42.

6.

Post-transplant lymphoproliferative disorders.

LaCasce AS.

Oncologist. 2006 Jun;11(6):674-80. Review.

7.

Epidemiology and etiology of non-Hodgkin lymphoma--a review.

Ekström-Smedby K.

Acta Oncol. 2006;45(3):258-71. Review.

PMID:
16644568
8.

Analytical methods and database design: implications for transplant researchers, 2005.

Levine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, Schaubel DE.

Am J Transplant. 2006;6(5 Pt 2):1228-42.

9.

Immunosuppression: evolution in practice and trends, 1994-2004.

Meier-Kriesche HU, Li S, Gruessner RW, Fung JJ, Bustami RT, Barr ML, Leichtman AB.

Am J Transplant. 2006;6(5 Pt 2):1111-31.

10.

The epidemiology of non-Hodgkin lymphoma.

Grulich AE, Vajdic CM.

Pathology. 2005 Dec;37(6):409-19. Review.

PMID:
16373224
11.

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression.

Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K.

Transplantation. 2005 Nov 15;80(9):1233-43.

PMID:
16314791
12.

Lymphoproliferative disease after renal transplantation in Australia and New Zealand.

Faull RJ, Hollett P, McDonald SP.

Transplantation. 2005 Jul 27;80(2):193-7.

PMID:
16041263
13.

Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.

Taylor AL, Marcus R, Bradley JA.

Crit Rev Oncol Hematol. 2005 Oct;56(1):155-67. Review.

PMID:
15979320
14.

Early onset post-transplant lymphoproliferative disease is associated with allograft localization.

Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ, Homan van der Heide JJ, Veeger NJ, Kluin PM, Kluin-Nelemans HC.

Clin Transplant. 2005 Jun;19(3):327-34.

PMID:
15877793
15.

Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?

Ghobrial IM, Habermann TM, Macon WR, Ristow KM, Larson TS, Walker RC, Ansell SM, Gores GJ, Stegall MD, McGregor CG.

Transplantation. 2005 Jan 27;79(2):244-7.

PMID:
15665775
16.

Epstein-Barr virus and lymphoproliferative disorders after transplantation.

[No authors listed]

Am J Transplant. 2004 Nov;4 Suppl 10:59-65. Review. No abstract available.

17.
18.

Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients.

Bustami RT, Ojo AO, Wolfe RA, Merion RM, Bennett WM, McDiarmid SV, Leichtman AB, Held PJ, Port FK.

Am J Transplant. 2004 Jan;4(1):87-93.

19.

Posttransplantation lymphoproliferative disorders.

Andreone P, Gramenzi A, Lorenzini S, Biselli M, Cursaro C, Pileri S, Bernardi M.

Arch Intern Med. 2003 Sep 22;163(17):1997-2004. Review.

PMID:
14504111
20.

Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.

Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA.

Transplantation. 2003 Mar 27;75(6):851-6.

PMID:
12660514
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk